Viemed Healthcare (VMD) Capital Leases (2023 - 2024)
Viemed Healthcare (VMD) posted Capital Leases of $28000.0 for Q2 2024, down 70.53% on a QoQ basis from $95000.0 in Q1 2024, and down 80.42% year-over-year from $143000.0 in Q3 2023.
Viemed Healthcare (VMD) Capital Leases (2023 - 2024) Analysis & Trends
Viemed Healthcare's Capital Leases history runs 2 years deep, the most recent figure standing at $28000.0 for Q2 2024.
- Quarterly Capital Leases fell 80.42% year-over-year to $28000.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $28000.0 (down 80.42% YoY) and the FY2023 annual result came in at $132000.0, changed N/A from the prior year.
- Capital Leases was $28000.0 for Q2 2024 at Viemed Healthcare, down from $95000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $180000.0 in Q3 2023 and bottomed at $28000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Viemed Healthcare | 448.46 Mn | 440.63 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 132,000.00 |
| Sep 30, 2023 | 180,000.00 |
| Jun 30, 2023 | 143,000.00 |